首页> 外文期刊>Small >NIR photoresponsive crosslinked upconverting nanocarriers toward selective intracellular drug release
【24h】

NIR photoresponsive crosslinked upconverting nanocarriers toward selective intracellular drug release

机译:NIR光响应交联的上转换纳米载体向选择性细胞内药物释放

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

An NIR-responsive mesoporous silica coated upconverting nanoparticle (UCNP) conjugate is developed for controllable drug delivery and fluorescence imaging in living cells. In this work, antitumor drug doxorubicin (Dox) molecules are encapsulated within cross-linked photocaged mesoporous silica coated UCNPs. Upon 980 nm light irradiation, Dox could be selectively released through the photocleavage of theo-nitrobenzyl (NB) caged linker by the converted UV emission from UCNPs. This NIR light-responsive nanoparticle conjugate demonstrates high efficiency for the controlled release of the drug in cancer cells. Upon functionalization of the nanocarrier with folic acid (FA), this photocaged FA-conjugated silica-UCNP nanocarrier will also allow targeted intracellular drug delivery and selective fluorescence imaging towards the cell lines with high level expression of folate receptor (FR).
机译:NIR响应介孔二氧化硅涂层的上转换纳米粒子(UCNP)共轭物被开发用于在活细胞中可控的药物递送和荧光成像。在这项工作中,抗肿瘤药物阿霉素(Dox)分子被封装在交联的光笼中孔二氧化硅包被的UCNPs中。在980 nm的光照射下,Dox可以通过邻硝基苄基(NB)笼状接头的光裂解,通过UCNP转换的UV发射选择性释放。这种NIR光响应性纳米颗粒共轭物显示出在癌细胞中药物受控释放的高效率。在用叶酸(FA)将纳米载体功能化后,这种光笼罩的FA共轭的二氧化硅-UCNP纳米载体还将允许靶向的细胞内药物递送和对具有高水平叶酸受体(FR)表达的细胞系的选择性荧光成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号